208 related articles for article (PubMed ID: 34048814)
1. SCN5A compound heterozygosity mutation in Brugada syndrome: Functional consequences and the implication for pharmacological treatment.
Joviano-Santos JV; Santos-Miranda A; Neri EA; Fonseca-Alaniz MH; Krieger JE; Pereira AC; Roman-Campos D
Life Sci; 2021 Aug; 278():119646. PubMed ID: 34048814
[TBL] [Abstract][Full Text] [Related]
2. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
[TBL] [Abstract][Full Text] [Related]
3. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
[TBL] [Abstract][Full Text] [Related]
4. Functional Characterization of Two Novel Mutations in
Balla C; Conte E; Selvatici R; Marsano RM; Gerbino A; Farnè M; Blunck R; Vitali F; Armaroli A; Brieda A; Liantonio A; De Luca A; Ferlini A; Rapezzi C; Bertini M; Gualandi F; Imbrici P
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204499
[TBL] [Abstract][Full Text] [Related]
5. A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.
Tan BY; Yong RY; Barajas-Martinez H; Dumaine R; Chew YX; Wasan PS; Ching CK; Ho KL; Gan LS; Morin N; Chong AP; Yap SH; Neo JL; Yap EP; Moochhala S; Chong DT; Chow W; Seow SC; Hu D; Uttamchandani M; Teo WS
Europace; 2016 Jun; 18(6):897-904. PubMed ID: 25829473
[TBL] [Abstract][Full Text] [Related]
6. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.
Zhang J; Chen Y; Yang J; Xu B; Wen Y; Xiang G; Wei G; Zhu C; Xing Y; Li Y
Eur J Pharmacol; 2015 Jan; 746():333-43. PubMed ID: 25261036
[TBL] [Abstract][Full Text] [Related]
8. Novel
Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
[TBL] [Abstract][Full Text] [Related]
9. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
[TBL] [Abstract][Full Text] [Related]
10. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
[TBL] [Abstract][Full Text] [Related]
11. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndrome.
Zeng Z; Zhou J; Hou Y; Liang X; Zhang Z; Xu X; Xie Q; Li W; Huang Z
PLoS One; 2013; 8(10):e78382. PubMed ID: 24167619
[TBL] [Abstract][Full Text] [Related]
13. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
[TBL] [Abstract][Full Text] [Related]
14. Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome.
Calloe K; Refaat MM; Grubb S; Wojciak J; Campagna J; Thomsen NM; Nussbaum RL; Scheinman MM; Schmitt N
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):177-84. PubMed ID: 23424222
[TBL] [Abstract][Full Text] [Related]
15. A novel missense mutation, I890T, in the pore region of cardiac sodium channel causes Brugada syndrome.
Tarradas A; Selga E; Beltran-Alvarez P; Pérez-Serra A; Riuró H; Picó F; Iglesias A; Campuzano O; Castro-Urda V; Fernández-Lozano I; Pérez GJ; Scornik FS; Brugada R
PLoS One; 2013; 8(1):e53220. PubMed ID: 23308164
[TBL] [Abstract][Full Text] [Related]
16. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
[TBL] [Abstract][Full Text] [Related]
17. p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient.
Núñez L; Barana A; Amorós I; de la Fuente MG; Dolz-Gaitón P; Gómez R; Rodríguez-García I; Mosquera I; Monserrat L; Delpón E; Caballero R; Castro-Beiras A; Tamargo J
Heart Rhythm; 2013 Feb; 10(2):264-72. PubMed ID: 23085483
[TBL] [Abstract][Full Text] [Related]
18. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations.
Béziau DM; Barc J; O'Hara T; Le Gloan L; Amarouch MY; Solnon A; Pavin D; Lecointe S; Bouillet P; Gourraud JB; Guicheney P; Denjoy I; Redon R; Mabo P; le Marec H; Loussouarn G; Kyndt F; Schott JJ; Probst V; Baró I
Basic Res Cardiol; 2014; 109(6):446. PubMed ID: 25341504
[TBL] [Abstract][Full Text] [Related]
19. Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome.
Cordeiro JM; Barajas-Martinez H; Hong K; Burashnikov E; Pfeiffer R; Orsino AM; Wu YS; Hu D; Brugada J; Brugada P; Antzelevitch C; Dumaine R; Brugada R
Circulation; 2006 Nov; 114(19):2026-33. PubMed ID: 17075016
[TBL] [Abstract][Full Text] [Related]
20.
Wijeyeratne YD; Tanck MW; Mizusawa Y; Batchvarov V; Barc J; Crotti L; Bos JM; Tester DJ; Muir A; Veltmann C; Ohno S; Page SP; Galvin J; Tadros R; Muggenthaler M; Raju H; Denjoy I; Schott JJ; Gourraud JB; Skoric-Milosavljevic D; Nannenberg EA; Redon R; Papadakis M; Kyndt F; Dagradi F; Castelletti S; Torchio M; Meitinger T; Lichtner P; Ishikawa T; Wilde AAM; Takahashi K; Sharma S; Roden DM; Borggrefe MM; McKeown PP; Shimizu W; Horie M; Makita N; Aiba T; Ackerman MJ; Schwartz PJ; Probst V; Bezzina CR; Behr ER
Circ Genom Precis Med; 2020 Dec; 13(6):e002911. PubMed ID: 33164571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
